サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1683394

スマート包帯の世界市場：2025年～2033年

Global Smart Bandages Market - 2025-2033

出版日
ページ情報
英文 159 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
スマート包帯の世界市場：2025年～2033年
出版日: 2025年03月20日
発行: DataM Intelligence
ページ情報: 英文 159 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のスマート包帯の市場規模は、2024年に8億2,378万米ドルに達し、2033年には32億2,730万米ドルに達すると予測され、予測期間の2025年～2033年のCAGRは14.6%になると見込まれています。

スマート包帯は、センサー、ドラッグデリバリーシステム、リアルタイムモニタリング機能を備えた高度な創傷ケア用包帯です。水分レベル、pHバランス、細菌感染などの創傷状態を追跡し、ヘルスケア専門家に貴重なデータを提供します。スマート・バンデージの中には、創傷部位に直接薬剤を投与することで、早期回復を促し、ドレッシング材の交換を減らすことができるものもあります。

こうした包帯は、慢性創傷、火傷、手術後のケアに特に有効で、合併症を最小限に抑え、患者の転帰を改善します。グラフェンやハイドロゲルのような素材の進歩により、スマート包帯はより柔軟で効率的になってきています。

世界のスマート包帯市場は、慢性創傷の増加、特に糖尿病、肥満、循環障害を持つ数100万人が罹患している慢性創傷の増加が牽引しています。従来の創傷治療法ではこうした状態の管理に苦慮しているため、スマート包帯のような高度なソリューションに対する需要が高まっています。これらの包帯は、リアルタイムのモニタリング、水分調節、ドラッグデリバリー機能を提供し、創傷治癒の結果を改善します。慢性創傷の発生率が高まるにつれ、スマート包帯の採用は拡大し、患者ケアの向上とヘルスケアコストの削減が期待されます。

例えば、NCBIの調査によると、新しい慢性創傷を持つ患者は年間866人で、年間平均54例でした。慢性潰瘍の開発率は人口1.2/1,000人で、有病率は3.3/1,000人でした。患者の多くは男性（57.2％）で、平均年齢は41.7歳±20.6歳でした。外傷後が主な原因であり、年齢は病因と正の相関があっています。鎌状赤血球および静脈性創傷は主に下肢にみられ、年齢が高くなるほど慢性創傷の発生と相関しました。

世界のスマート包帯市場は、FDAとEMAが定める厳しい規制承認プロセスによる課題に直面しています。この複雑なプロセスは、製品上市の遅延を引き起こし、市場参入の時間と投資を増加させ、異なる地域のメーカーにとって世界な商業化を困難にし、市場の成長を制限する可能性があります。

当レポートでは、世界のスマート包帯市場について調査し、市場の概要とともに、製品タイプ別、技術別、用途別、流通チャネル別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 市場のイントロダクションと範囲

第2章 エグゼクティブの洞察と重要なポイント

第3章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第4章 戦略的洞察と業界の展望

  • 市場のリーダーと先駆者
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格動向
  • キーオピニオンリーダー

第5章 スマート包帯市場、製品タイプ別

  • グラフェン包帯
  • 合成繊維包帯

第6章 スマート包帯市場、技術別

  • ワイヤレスセンサー
  • フレキシブル電子

第7章 スマート包帯市場、用途別

  • 火傷による慢性皮膚損傷
  • 糖尿病による慢性皮膚創傷
  • その他の原因による慢性皮膚創傷

第8章 スマート包帯市場、流通チャネル別

  • 小売薬局
  • 病院薬局
  • その他

第9章 スマート包帯市場、地域別市場分析と成長機会

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他
  • 中東・アフリカ

第10章 競合情勢と市場ポジショニング

第11章 企業プロファイル

  • Grapheal
  • 3M Company
  • The Wound Pros, Inc
  • Baxter International Inc
  • Coloplast A/S
  • SURVIVAL

第12章 仮定と調査手法

第13章 付録

目次
Product Code: MD9334

The global smart bandages market reached US$ 823.78 million in 2024 and is expected to reach US$ 3227.30 million by 2033, growing at a CAGR of 14.6% during the forecast period 2025-2033.

Smart bandages are advanced wound care dressings with sensors, drug delivery systems, and real-time monitoring capabilities. They track wound conditions like moisture levels, pH balance, and bacterial infections, providing valuable data to healthcare professionals. Some smart bandages can deliver medications directly to the wound site, promoting faster recovery and reducing dressing changes.

These dressings are particularly beneficial for chronic wounds, burns, and post-surgical care, minimizing complications and improving patient outcomes. With advancements in materials like graphene and hydrogel, smart bandages are becoming more flexible and efficient.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Chronic Wounds

The global smart bandages market is driven by the rise in chronic wounds, particularly those affecting millions of people with diabetes, obesity, and circulatory disorders. Traditional wound care methods struggle to manage these conditions, leading to a demand for advanced solutions like smart bandages. These dressings offer real-time monitoring, moisture regulation, and drug delivery capabilities, improving wound healing outcomes. As chronic wound incidence increases, smart bandage adoption is expected to grow, enhancing patient care and reducing healthcare costs.

For instance, according to an NCBI study, 866 patients with new chronic wounds were seen annually, with an average of 54 cases per year. Chronic ulcers develop at a rate of 1.2/1000 population, with a prevalence of 3.3/1000. Most patients were males (57.2%), with a mean age of 41.7 years +- 20.6. Post-traumatic wounds were the leading cause, with age positively correlated with aetiology. Sickle cell and venous wounds were predominantly on the legs, with an increasing age correlated with chronic wound occurrence.

Regulatory Challenges

The global smart bandage market faces challenges due to the stringent regulatory approval process set by the FDA and EMA, which requires medical devices to meet strict safety and efficacy standards. This complex process can cause delays in product launches, increase market entry time and investment, and make global commercialization challenging for manufacturers across different regions, limiting market growth.

Segment Analysis

The global smart bandages market is segmented based on product type, technology, application, distribution channel, and region.

Product Type:

The graphene-based bandages from the application segment are expected to dominate the smart bandages market with the highest market share

Graphene-based bandages are transforming the global smart bandages market by offering superior wound healing capabilities. Their exceptional electrical conductivity allows real-time wound monitoring, enabling early detection of infections. Graphene's high mechanical strength and flexibility ensure durability and patient comfort. Its natural antimicrobial properties reduce infection risk, making it beneficial for chronic wounds, burns, and diabetic ulcers. These bandages can also be integrated with drug delivery systems for controlled medication release. As demand for tech-enabled wound care solutions increases, graphene-based bandages are expected to drive significant advancements.

Geographical Analysis

North America is expected to hold a significant position in the Smart Bandages market with the highest market share

The North American smart bandages market is fueled by chronic wounds, such as diabetic ulcers and pressure sores, due to the aging population and diabetes cases. The region's strong healthcare infrastructure and reimbursement policies support advanced wound care solutions. Technological advancements, such as sensors and real-time monitoring, enhance the effectiveness of smart bandages. Leading medical device companies and substantial research investments fuel market growth. Growing awareness among healthcare professionals and patients about smart bandage benefits and increasing home healthcare adoption contribute to market expansion.

For instance, in June 2024, Chronic wounds, including diabetic ulcers and pressure injuries, have a poorer five-year survival rate than other serious diseases and cost an estimated $28 billion annually in the U.S. Treating wounds is expensive, with researchers from the Keck School of Medicine of USC and the California Institute of Technology developing advanced technologies to revolutionize wound care. These technologies include smart bandages that automatically respond to changing wound conditions, providing continuous data on healing and potential complications and enabling real-time delivery of medications or treatments.

Competitive Landscape

The major global players in the smart bandages market include Grapheal, 3M Company, The Wound Pros, Inc, Baxter International Inc, Coloplast A/S, SURVIVAL and among others.

Key Developments

  • In June 2024, the Keck School of Medicine of USC and the California Institute of Technology developed advanced technologies, including smart bandages, to revolutionize wound care by automatically sensing and responding to changing conditions, providing continuous data on healing and potential complications, and potentially delivering drugs or treatments in real time.
  • In May 2024, Researchers from the University of Southampton are developing smart bandages that enable remote monitoring and use LED lights to sterilize wounds as they heal, using ultraviolet-C light for treatment.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyze product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global smart bandages market report delivers a detailed analysis with 70 key tables, more than 65 visually impactful figures, and 159 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Technology
  • 2.5. Snippet by Application
  • 2.6. Snippet by Distribution Channel
  • 2.7. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Chronic Wounds
      • 3.1.1.2. Advancements in Wearable Technologies
    • 3.1.2. Restraints
      • 3.1.2.1. Regulatory Challenges
      • 3.1.2.2. Technical Limitations
    • 3.1.3. Opportunity
      • 3.1.3.1. Emerging Markets Expansion
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. CXO Perspectives
  • 4.3. Latest Developments and Breakthroughs
  • 4.4. Case Studies/Ongoing Research
  • 4.5. Regulatory and Reimbursement Landscape
    • 4.5.1. North America
    • 4.5.2. Europe
    • 4.5.3. Asia Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East & Africa
  • 4.6. Porter's Five Forces Analysis
  • 4.7. Supply Chain Analysis
  • 4.8. Patent Analysis
  • 4.9. SWOT Analysis
  • 4.10. Unmet Needs and Gaps
  • 4.11. Recommended Strategies for Market Entry and Expansion
  • 4.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.13. Pricing Analysis and Price Dynamics
  • 4.14. Key Opinion Leaders

5. Smart Bandages Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Graphene-Based Bandages*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Synthetic Fiber Bandages

6. Smart Bandages Market, By Technology

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 6.1.2. Market Attractiveness Index, By Technology
  • 6.2. Wireless Sensors*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Flexible Electronic

7. Smart Bandages Market, By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Chronic Skin Wounds from Burns*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Chronic Skin Wounds from Diabetes
  • 7.4. Chronic Skin Wounds from Other Causes

8. Smart Bandages Market, By Distribution Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 8.1.2. Market Attractiveness Index, By Distribution Channel
  • 8.2. Retail Pharmacies*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Hospital Pharmacies
  • 8.4. Others

9. Smart Bandages Market, By Regional Market Analysis and Growth Opportunities

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.7.1. U.S.
      • 9.2.7.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.7.1. Germany
      • 9.3.7.2. U.K.
      • 9.3.7.3. France
      • 9.3.7.4. Spain
      • 9.3.7.5. Italy
      • 9.3.7.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Mexico
      • 9.4.7.2. Brazil
      • 9.4.7.3. Argentina
      • 9.4.7.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 9.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.7.1. China
      • 9.5.7.2. India
      • 9.5.7.3. Japan
      • 9.5.7.4. South Korea
      • 9.5.7.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

10. Competitive Landscape and Market Positioning

  • 10.1. Competitive Overview and Key Market Players
  • 10.2. Market Share Analysis and Positioning Matrix
  • 10.3. Strategic Partnerships, Mergers & Acquisitions
  • 10.4. Key Developments in Product Portfolios and Innovations
  • 10.5. Company Benchmarking

11. Company Profiles

  • 11.1. Grapheal*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals, etc.
    • 11.1.5. SWOT Analysis
  • 11.2. 3M Company
  • 11.3. The Wound Pros, Inc
  • 11.4. Baxter International Inc
  • 11.5. Coloplast A/S
  • 11.6. SURVIVAL

LIST NOT EXHAUSTIVE

12. Assumption and Research Methodology

  • 12.1. Data Collection Methods
  • 12.2. Data Triangulation
  • 12.3. Forecasting Techniques
  • 12.4. Data Verification and Validation

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us